-
Mashup Score: 46ASH 2023 login - 11 month(s) ago
This site is intended for attendees of the congress where the research is presented and limited to healthcare professionals. This site contains scientific presentations on investigational products and/or investigational uses of approved products for Janssen-sponsored studies. Some studies sponsored by Janssen’s research …
Source: www.congresshub.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 18Janssen Science Hub - ESMO 2023 login - 1 year(s) ago
This site is intended for attendees of the congress where the research is presented and limited to healthcare professionals. This site contains scientific presentations on investigational products and/or investigational uses of approved products for Janssen-sponsored studies. Some studies sponsored by Janssen’s research and development partners may be…
Source: www.congresshub.comCategories: General Medicine News, UrologyTweet-
@AndreaNecchi with results of #TAR200 — intravesical gemcitabine in BCG refractory non muscle invasive #bladdercancer. Nice 77% CR and duration of responses! https://t.co/oLLeYMH3Hc @myESMO #ESMO23 @OncoAlert https://t.co/gjDvSpVOfU https://t.co/AQZYm0ip5F
-
-
Mashup Score: 18Janssen Science Hub - ESMO 2023 login - 1 year(s) ago
This site is intended for attendees of the congress where the research is presented and limited to healthcare professionals. This site contains scientific presentations on investigational products and/or investigational uses of approved products for Janssen-sponsored studies. Some studies sponsored by Janssen’s research and development partners may be…
Source: www.congresshub.comCategories: General Medicine News, UrologyTweet-
@AndreaNecchi with results of #TAR200 — intravesical gemcitabine in BCG refractory non muscle invasive #bladdercancer. Nice 77% CR and duration of responses! https://t.co/oLLeYMH3Hc @myESMO #ESMO23 @OncoAlert https://t.co/gjDvSpVOfU https://t.co/AQZYm0ip5F
-
-
Mashup Score: 6Janssen Science Hub - IMS 2023 login - 1 year(s) ago
This site is intended for attendees of the congress where the research is presented and limited to healthcare professionals. This site contains scientific presentations on investigational products and/or investigational uses of approved products for Janssen-sponsored studies. Some studies sponsored by Janssen’s research and development partners may be…
Source: www.congresshub.comCategories: Latest Headlines, Partners & KOLsTweet-
It is hard to take an indirect adjusted comparison seriously when the Kaplan Meier curves have already separated at time 0. Literally the green curve is starting from below the blue curve 😲 #mmsm https://t.co/XKzNa4MwBw https://t.co/udcmgq0yGj
-
Interesting tidbits after ASH. Looking at the effectiveness of therapy after talquetamab in patients enrolled in the MonumenTAL-1 Phase 1/2 study. BOTTOM LINE: Usual therapies in advanced MM are not very effective. https://t.co/GV9YoQmvRd #ASCO23RF #mmsm https://t.co/In3YQS2vlw